TCS recognized as leader in Life Science Manufacturing and Supply Chain ITO

TCS was recognized for its overall capability and extensive experience working with Life Science companies across all three sections of the industry: pharmaceutical, biotech and medical devices.

 

The report evaluated the top 14 leading IT vendors that serve the Life Science Manufacturing and Supply Chain space across a number of services such as system implementation, systems integration, data integration, application development, maintenance, support, and infrastructure outsourcing. IDC MarketScape criteria of selection, weightings and vendor scores represent well-researched IDC judgment about the market and vendors through structured discussions, surveys and interviews with market leaders, participant buyers and end users.

 

“There continues to be strong demand in Life Sciences for external partners that have strong industry expertise and can help achieve corporate goals through better, cheaper, and more flexible use of manufacturing and supply chain–focused technology,” said Eric Newmark, Program Director, IDC Health Insights, Business Systems Strategies Program. “TCS has demonstrated its expertise and innovation through its extensive work with Life Sciences companies in the Manufacturing and Supply Chain market. TCS’ exceptional technical skills and project management capabilities, coupled with the overall value that the company consistently delivers to its clients, make it a leader in the field.”

 

“Life Sciences manufacturers today are under increasing pressure to improve supply chain efficiency and agility, as well as eliminate waste from entire manufacturing and supply chain processes,” said Debashis Ghosh, President - Life Sciences, Manufacturing and Energy, TCS. “IDC’s recognition in the manufacturing and supply chain space is a testament to the unparalleled service and solutions that TCS offers to its Life Science customers. With our continuous domain focus, innovation and expanding global footprint, we will continue to add value for Life Sciences companies worldwide.”